Robert Lloyd Email & Phone Number

Seattle, Washington, United States

Development and execution of ddPCR and NGS assays to support many drug development programs across the research arm of Shape Therapeutics.

Seattle, Washington, United States

Leveraged knowledge of AAV vector design and analytics to produce and characterize novel AAV variantsIn June 2023, I transitioned to development and execution of ddPCR and NGS assays to support numerous drug development programs across the research arm of Shape Therapeutics

Seattle, Washington

Cloning, small-scale production, and analytical development of AAV vectors. Included assay development to support Shape's TruStable cell line.

United States

R&D to develop novel bacterially-vectored live-attenuated vaccines. Duties include molecular cloning, bacterial cell culture, and clone screening by PCR, Western Blot, and other molecular methods.

United States

Supervised/mentored junior QC analysts while overseeing the technology transfer and qualification/validation of qPCR and ddPCR assays. Created/revised Standard Operating Procedures. Served as Subject Matter Expert on PCR-based assays for the QC department, and conducted OOS/OOT investigations related to those assays as required.

Alachua, Fl

Performed qPCR, Western Blot, and replication-competent AAV screening assays in a cGMP-compliant laboratory in support of drug product release and product stability studies.

Alachua, Fl

Performed qPCR, Western Blot, and replication-competent AAV screening assays in a cGMP-compliant laboratory in support of drug product release and product stability studies.